2019
DOI: 10.1007/s00701-019-03800-z
|View full text |Cite
|
Sign up to set email alerts
|

Disseminated central nervous system hemangioblastoma in a patient with no clinical or genetic evidence of von Hippel-Lindau disease—a case report and literature review

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
19
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 7 publications
(19 citation statements)
references
References 22 publications
0
19
0
Order By: Relevance
“…After an extensive review of the literature in PubMed and Google Scholar using the terms “Hemangioblastoma,” “Hemangioblastomatosis,” “Leptomeningeal dissemination,” and “von Hippel–Lindau,” we found 30 similar cases reported in the past 46 years [ Table 1 ]. [ 1 - 4 , 6 , 8 , 10 , 13 , 15 , 17 , 19 , 20 , 22 - 27 , 30 , 32 , 33 ]…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…After an extensive review of the literature in PubMed and Google Scholar using the terms “Hemangioblastoma,” “Hemangioblastomatosis,” “Leptomeningeal dissemination,” and “von Hippel–Lindau,” we found 30 similar cases reported in the past 46 years [ Table 1 ]. [ 1 - 4 , 6 , 8 , 10 , 13 , 15 , 17 , 19 , 20 , 22 - 27 , 30 , 32 , 33 ]…”
Section: Discussionmentioning
confidence: 99%
“…In many studies, patients died within 4 years of the diagnosis of CNS dissemination. [ 1 , 4 , 17 , 19 , 22 , 27 , 32 , 33 ] In one study, the patient survived for 10 years after the dissemination. [ 8 ] In some studies, the patients were still alive at the time of publication, but with short follow-up periods or ongoing cases.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…These tumours account for 1%–2% of all primary central nervous system tumours 1 2. Sporadic HB is usually solitary and accounts for 70%–75% of cases, whereas in 25%–30% of patients, it is a manifestation of von Hippel-Lindau (VHL) disease with multifocal HBs 3 4. The mutated gene in VHL disease is a tumour suppressor gene located on the short arm of chromosome 3 3 5 6.…”
Section: Introductionmentioning
confidence: 99%
“…Sporadic HB is usually solitary and accounts for 70%–75% of cases, whereas in 25%–30% of patients, it is a manifestation of von Hippel-Lindau (VHL) disease with multifocal HBs 3 4. The mutated gene in VHL disease is a tumour suppressor gene located on the short arm of chromosome 3 3 5 6. In addition to HBs, multiple visceral neoplasms are characteristic of VHL disease, including renal clear cell carcinoma, pheochromocytoma and pancreatic neuroendocrine tumour 1 7–11.…”
Section: Introductionmentioning
confidence: 99%